"The FDA review found a "differential risk of antidepressant-induced
suicidality across the age spectrum" with the risk of suicidal
behaviors being at the younger end of the spectrum and that it
declined with age with a greater "protective" effect in adults aged
65 and older." WSJ
Powered by LSoft's LISTSERV(R) list management software